NFKB p65(acetyl K310) polyclonal antibody, Unconjugated, Rabbit

Article Name:	NFKB p65(acetyl K310) polyclonal antibody, Unconjugated, Rabbit
Biozol Catalog Number:	BWT-BS66118
Supplier Catalog Number:	BS66118
Alternative Catalog Number:	BWT-BS66118-50UL,BWT-BS66118-100UL
Manufacturer:	Bioworld Technology
Host:	Rabbit
Category:	Antikörper
Application:	ELISA, WB
Species Reactivity:	Human, Mouse, Rat
Immunogen:	KLH conjugated Synthesised acetylpeptide derived from human NFKBp65 around the acetylation site of Lys310: TF(Ac-K)SI
Conjugation:	Unconjugated
Alternative Names:	NF-kB p65 (acetyl K310), NF-kappaB p65(acetyl K310), RELA(acetyl K310), NF kB P65, NF-kB p65, NFKBp65, NF-kappaBp65, p65 NF kappaB, p65 NFkB, NFKBp65, RELA, Transcription Factor p65, v rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B cells 3 (p65)), V Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A, v rel reticuloendotheliosis viral oncogene homolog A (avian), v-rel reticuloendotheliosis viral oncogene homolog A, p65NFKB, Avian reticuloendotheliosis viral (v rel) oncogene homolog A, MGC131774, NFKB 3, NFKB3, Nuclear Factor NF Kappa B p65 Subunit, Nuclear factor of kappa light polypeptide gene enhancer in B cells 3, Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B Cells, TF65_HUMAN. NFkappaB-p65, NFkappaB p65, NF kappaB-p65, NFkappaBp65

NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappa-B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-kappa-B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1.

Molecular Weight:	~ 61 kDa
UniProt:	Q04206
Purity:	The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Form:	0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Application Dilute:	WB: 1:500-1:2000 ELISA: 1:5000-1:10000
Application Notes:	NFKB p65(acetyl K310) polyclonal antibody detects endogenous levels of NFKB p65(acetyl) protein.